These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36124859)

  • 1. Discovery of pyrazole-1-carboxamide derivatives as novel Gi-biased μ-opioid receptor agonists.
    Jung JH; Jang IH; Kim YO; Kim S; Yoon MH; Kim YC
    Drug Dev Res; 2022 Nov; 83(7):1600-1612. PubMed ID: 36124859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
    Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
    Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
    Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain.
    Ma M; Li X; Tong K; Cheng J; Yu Z; Ren F; Zhong B; Shi W
    ChemMedChem; 2020 Jan; 15(1):155-161. PubMed ID: 31729174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased Opioid Ligands.
    Faouzi A; Varga BR; Majumdar S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
    Lei W; Vekariya RH; Ananthan S; Streicher JM
    J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Opioid Analgesics for the Development of Transdermal Opioid Patches That Possess Morphine-Like Pharmacological Profiles Rather Than Fentanyl: Possible Opioid Switching Alternatives Among Patch Formula.
    Komatsu A; Miyano K; Nakayama D; Mizobuchi Y; Uezono E; Ohshima K; Karasawa Y; Kuroda Y; Nonaka M; Yamaguchi K; Iseki M; Uezono Y; Hayashida M
    Anesth Analg; 2022 May; 134(5):1082-1093. PubMed ID: 35427270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
    Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
    Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists.
    Li X; Guo Y; Li J; Yu Z; Cheng J; Ren F; Jia H; Zhang Y; Cui S; Zhang T; Shi W
    ChemMedChem; 2022 Dec; 17(24):e202200416. PubMed ID: 36210341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics.
    Grim TW; Acevedo-Canabal A; Bohn LM
    Biol Psychiatry; 2020 Jan; 87(1):15-21. PubMed ID: 31806082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat.
    Araldi D; Ferrari LF; Levine JD
    Neuroscience; 2018 Dec; 394():60-71. PubMed ID: 30342200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias.
    Yang Y; Wang Y; Zuo A; Li C; Wang W; Jiang W; Zhang X; Che X; Zhang Y; Wu W; Cen X; Wang H; Tian J
    Eur J Med Chem; 2022 Jan; 228():113986. PubMed ID: 34802839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the development of more effective and safer analgesics for pain management.
    Turnaturi R; Chiechio S; Salerno L; Rescifina A; Pittalà V; Cantarella G; Tomarchio E; Parenti C; Pasquinucci L
    Eur J Med Chem; 2019 Dec; 183():111701. PubMed ID: 31550662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Biased Opioid Receptor Ligands through Structure-Based Pharmacophore Virtual Screening and Experiment.
    Jeong P; Kim SK; Li Q; Oh SJ; Son S; Chen G; Tan H; Kim S; Park JH; Park KD; Kim YO; Yoon MH; Kim YC; Goddard WA
    ChemMedChem; 2019 Oct; 14(20):1783-1794. PubMed ID: 31359587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor.
    Ramos-Gonzalez N; Groom S; Sutcliffe KJ; Bancroft S; Bailey CP; Sessions RB; Henderson G; Kelly E
    Br J Pharmacol; 2023 Sep; 180(18):2341-2360. PubMed ID: 37005796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Binding Mechanism of Pyrazoloisoquinoline-Based Novel β-Arrestin Inverse Agonists of the Kappa-Opioid Receptor.
    Jung JH; Jang IH; Yang MY; Kim S; Kim SK; Goddard WA; Kim YC
    J Med Chem; 2023 Apr; 66(7):5154-5170. PubMed ID: 36987735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.
    Narayan A; Hunkele A; Xu J; Bassoni DL; Pasternak GW; Pan YX
    Cell Mol Neurobiol; 2021 Jul; 41(5):1059-1074. PubMed ID: 33033993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways.
    Karasawa Y; Miyano K; Fujii H; Mizuguchi T; Kuroda Y; Nonaka M; Komatsu A; Ohshima K; Yamaguchi M; Yamaguchi K; Iseki M; Uezono Y; Hayashida M
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.